Psychopharmacology

, Volume 97, Issue 2, pp 213–218

Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors

  • J. C. Neill
  • S. J. Cooper
Original Investigations

Abstract

The effects of eight serotonin (5-HT) receptor antagonists on the anorectic effect of d-fenfluramine (3.0 mg/kg, IP) were examined in a test of sweet mash consumption, using non-deprived male rats. d-Fenfluramine's effect was attenuated by the mixed 5-HT1/5-HT2 receptor antagonists, methiothepin and metergoline; by the 5-HT2 receptor antagonist ritanserin; and by (±)cyanopindolol, a mixed 5-HT1A/5-HT1B receptor antagonist. In contrast, d-fenfluramine's effect was not antagonised by the 5-HT2 receptor antagonists ketanserin and ICI 169 369; the 5-HT3 receptor antagonist ICS 205 930; or by xylamidine, a peripheral 5-HT receptor antagonist. In this feeding model, none of the 5-HT antagonists, when tested alone, had any effect to increase palatable food consumption. The pattern of results obtained strongly suggest that central 5-HT1 receptors play an important role in the mediation of d-fenfluramine-induced anorexia.

Key words

d-Fenfluramine 5-HT receptor subtypes Methiothepin Metergoline Ketanserin Ritanserin (±)Cyanopindolol ICI 169 369 ICS 205 930 Xylamidine Anorexia Rats 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baker BJ, Duggan JP, Barber DJ, Booth DA (1988) Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats. Eur J Pharmacol 150: 137–142Google Scholar
  2. Barrett AM, McSharry L (1975) Inhibition of drug-induced anorexia in rats by methysergide. J Pharma Pharmacol 27: 889–895Google Scholar
  3. Blackburn TP, Thornber CW, Pearce RJ, Cox B (1987) In vivo pharmacology of ICI 169 369 — a new 5-HT2 antagonist. Br J Pharmacol 90: 277PGoogle Scholar
  4. Blundell JE (1984) Serotonin and appetite. Neuropharmacology 23: 1537–1551Google Scholar
  5. Blundell JE, Latham CJ (1980) Characterisation of adjustments to the structure of feeding behavior following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and metergoline. Pharmacol Biochem Behav 12: 717–722Google Scholar
  6. Borsini F, Bendotti C, Aleotti A, Samanin R, Garattini S (1982) d-Fenfluramine and d-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain. Pharmacol Res Commun 14: 671–678Google Scholar
  7. Borsini F, Bendotti C, Samanin R (1985) Salbutamol, d-amphetamine and d-fenfluramine reduce sucrose intake in freely fed rats by acting on different neurochemical mechanisms. Int J Obes 9: 277–283Google Scholar
  8. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576Google Scholar
  9. Carruba MO, Mantegazza P, Memo M, Missale C, Spano PF (1986) Peripheral and central mechanisms of action of serotonergic anorectic drugs. Appetite [Suppl] 7: 105–113Google Scholar
  10. Clineschmidt BV, McGuffin JC, Werner AB (1974) Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloroamphetamine. Eur J Pharmacol 27: 313–323Google Scholar
  11. Cooper SJ (1986) Hyperphagic and anorectic effects of β-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam. Eur J Pharmacol 120: 257–265Google Scholar
  12. Copp FC, Green AF, Hodson HF, Randall AW, Sim MF (1967) New peripheral antagonists of 5-hydroxytryptamine. Nature 214: 200–201Google Scholar
  13. Dourish CT, Cooper SJ, Gilbert F, Coughlan J, Iversen SD (1988a) The 5-HT1A agonist 8-OH-DPAT increases consumption of palatable wet mash and liquid diets in the rat. Psychopharmacology 94: 58–63Google Scholar
  14. Dourish CT, Clark ML, Fletcher A, Iversen SD (1988b) Evidence that blockade of postsynaptic 5-HT1 receptors elicits feeding in satiated rats. Psychopharmacology (in press)Google Scholar
  15. Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332: 1–7Google Scholar
  16. Fletcher PJ (1987) Serotonin antagonists and feeding. Soc Neurosci Abstr 13: 1173Google Scholar
  17. Fletcher PJ, Burton MJ (1986) Dissociation of the anorectic actions of 5-HTP and fenfluramine. Psychopharmacology 89: 216–220Google Scholar
  18. Fuller RW, Kurz KD, Mason NR, Cohen MC (1986) Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Eur J Pharmacol 125: 71–77Google Scholar
  19. Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R (1986a) Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite [Suppl] 7: 15–38Google Scholar
  20. Garattini S, Mennini T, Samanin R (1986b) From fenfluramine racemate to d-fenfluramine; specificity and potency of the effects on the serotoninergic system and food intake. Ann NY Acad Sci 499: 156–166Google Scholar
  21. Heuring RE, Peroutka SJ (1987) Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7: 894–903Google Scholar
  22. Hewson G, Leighton GE, Hill RG, Hughes J (1988) Ketanserin antagonises the anorectic effect of dl-fenfluramine in the rat. Eur J Pharmacol 145:227–230Google Scholar
  23. Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res (in press)Google Scholar
  24. Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]cyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118: 13–23Google Scholar
  25. Invernizzi R, Berettera C, Garattini S, Samanin R (1986) d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120: 9–15Google Scholar
  26. Jespersen J, Scheel-Krüger J (1973) Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia. J Pharm Pharmacol 25: 49–54Google Scholar
  27. Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28: 1015–1022Google Scholar
  28. Leysen JE, Gommeren W, Van Gompel P, Wynans J, Janssen PAJ, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27: 600–611Google Scholar
  29. Massi M, Marini S (1987) Effect of the 5-HT2 antagonist ritanserin on food intake and on 5-HT-induced anorexia in the rat. Pharmacol Biochem Behav 26: 333–340Google Scholar
  30. Mawson C, Whittington H (1970) Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol 39: 223PGoogle Scholar
  31. Middlemiss DN, Hibert M, Fozard JR (1986) Drugs acting at central 5-hydroxytryptamine receptors. Annu Rep Med Chem 21: 41–50Google Scholar
  32. Neill JC, Cooper SJ (1988) Evidence for serotonergic modulation of sucrose sham-feeding in the gastric-fistulated rat. Physiol Behav (in press)Google Scholar
  33. Pazos A, Hoyer D, Palacios JM (1985) The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur J Pharmacol 106: 539–546Google Scholar
  34. Pedigo NW, Yamamura HI, Nelson DC (1981) Discrimination of multiple 3H 5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36: 220–226Google Scholar
  35. Pollock JD, Rowland N (1981) Peripherally administered serotonin decreases food intake in rats. Pharmacol Biochem Behav 15: 179–183Google Scholar
  36. Simansky KJ, Cohen BI, Eberle K (1987) Inhibition by 5-HT2 antagonists of the anorexic actions of peripherally administered 5-hydroxytryptamine (5-HT) and 4-HT in rats. Soc Neurosci Abstr 13: 15Google Scholar
  37. Richardson BP, Engel G, Donatsch P, Stadler PA (1985) Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316: 126–131Google Scholar
  38. Rowland NE, Carlton J (1986) Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27: 13–62Google Scholar
  39. Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New YorkGoogle Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • J. C. Neill
    • 1
  • S. J. Cooper
    • 1
  1. 1.School of PsychologyUniversity of BirminghamBirminghamUK

Personalised recommendations